Rhumbline Advisers 908 Devices Inc. Transaction History
Rhumbline Advisers
- $109 Billion
- Q3 2024
A detailed history of Rhumbline Advisers transactions in 908 Devices Inc. stock. As of the latest transaction made, Rhumbline Advisers holds 34,744 shares of MASS stock, worth $76,436. This represents 0.0% of its overall portfolio holdings.
Number of Shares
34,744
Previous 37,696
7.83%
Holding current value
$76,436
Previous $194,000
38.14%
% of portfolio
0.0%
Previous 0.0%
Shares
15 transactions
Others Institutions Holding MASS
# of Institutions
88Shares Held
18.4MCall Options Held
14.1KPut Options Held
22K-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl3.22MShares$7.08 Million0.11% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.88MShares$4.13 Million0.0% of portfolio
-
Ameriprise Financial Inc Minneapolis, MN1.84MShares$4.05 Million0.0% of portfolio
-
Black Rock Inc. New York, NY1.69MShares$3.73 Million0.0% of portfolio
-
Awm Investment Company, Inc. New York, NY1.57MShares$3.46 Million0.75% of portfolio
About 908 Devices Inc.
- Ticker MASS
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 31,590,200
- Market Cap $69.5M
- Description
- 908 Devices Inc., a commercial-stage technology company, provides various purpose-built handheld and desktop mass spectrometry (Mass Spec) devices to interrogate unknown and invisible materials in life sciences research, bioprocessing, industrial biotech, forensics, and adjacent markets. The company's products include MX908, a handheld, battery-...